Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 10
Submit an article Journal homepage
434
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Surrogate end points for long-term outcomes in chronic myeloid leukemia

Frank AkwaaSchool of Medicine, University of Rochester, Rochester, NY, USA
&
Jane LiesveldSchool of Medicine, University of Rochester, Rochester, NY, USACorrespondence[email protected]
Pages 2103-2111 | Received 30 Oct 2012, Accepted 30 Jan 2013, Published online: 08 Mar 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carmen Fava, Alessandro Morotti, Irene Dogliotti, Giuseppe Saglio & Giovanna Rege-Cambrin. (2015) Update on emerging treatments for chronic myeloid leukemia. Expert Opinion on Emerging Drugs 20:2, pages 183-196.
Read now

Articles from other publishers (4)

Franck-Emmanuel Nicolini, Françoise Huguet, Lynn Huynh, Churong Xu, Christophe Bouvier, Aurore Yocolly & Gabriel Etienne. (2023) A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation. Cancers 15:16, pages 4161.
Crossref
Bin Wu, Maobai Liu, Te Li, Houwen Lin & Hua Zhong. (2017) An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China. Medicine 96:29, pages e7445.
Crossref
Madhu Kalia. (2015) Biomarkers for personalized oncology: recent advances and future challenges. Metabolism 64:3, pages S16-S21.
Crossref
Jo?lle Guilhot, Claude Preudhomme, Francois Xavier Mahon & Fran?ois Guilhot. (2015) Analyzing molecular response in chronic myeloid leukemia clinical trials: Pitfalls and golden rules. Cancer 121:4, pages 490-497.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.